Marijuana recall issued for three Michigan dispensaries

FILE - This Sept. 11, 2018, file photo shows blankets of frost known as trichomes on a budding marijuana flower at an artisanal cannabis farm SLOgrown Genetics, the coastal mountain range of San Luis Obispo, Calif. Liberal California became the largest legal U.S. marketplace, while conservative Utah and Oklahoma embraced medical marijuana. (AP Photo/Richard Vogel,File)

A marijuana recall was issued for a medical marijuana dispensary in Kalamazoo, Detroit and Lansing.

An patient or caregiver should return the product under the recall to the location it was obtained so it can be disposed of properly.

The Michigan Department of Licensing and Regulatory Affairs (LARA) issued the health and safety advisory because certain strains of marijuana sold at Compassionate Care by Design, 401 N. Sage St. failed laboratory testing.

The products were sold between Dec. 12, 2018 and Dec. 29, 2018. The products contained chemical residue.

The products and batch numbers are listed:

  • Critical Cali: 1A4040100000515000000014
  • GMO: 1A4040100000515000000015
  • Silver Haze: 1A4040100000515000000016
  • GSC: 1A4040100000515000000017
  • Critical Kush: 1A4040100000515000000018
  • Blueberry: 1A4040100000515000000019
  • Skunk #1: 1A4040100000515000000020
  • Chunk D: 1A4040100000515000000021
  • Amnesia Lemon Kush: 1A4040100000515000000022
  • Special Kush: 1A4040100000515000000023
  • Purple Punch: 1A4040100000515000000024

A representative from Compassionate Care by Design, Inc. sent a statement:

The product recall for Compassionate Care By Design, Inc. is due to a misunderstanding between CCBD and the testing facility that tested these products. CCBD received test results that stated “passed” when in reality these products failed compliant testing.
In the month of December the State and LARA allowed all Medical Marijuana facilities to sell products from Caregivers without having that product tested to the state compliance standards as long as a consent form was signed by each patient outlining their understanding that the products they were purchasing were not tested to state compliance standards. CCBD has signed consent forms from their patients that purchased products during this period but will be reaching out to each patient individually if they purchased a product falling under the recall. CCBD has received no reports of any adverse effects from any patient that purchased products under the recall. We apologize for any confusion that this may have caused as patient safety and well being is of the utmost importance to us. Thank you, Compassionate Care By Design, Inc.

The Green Mile, 6650 E. Eight Mile Rd., in Detroit had product recalled that was sold between Dec. 18, 2018, and Jan. 3, 2019.

The products, batch number and reason for recall are listed:

  • Gelato: 1A405010000076E000000140 - Failed for total yeast and mold.
  • Superman OG: 1A405010000076E000000141 - Failed for chemical residue.
  • Mimosa: 1A405010000076E000000125 - Failed for bile-tolerant gram-negative bacteria and total coliforms.
  • Girl Scout Cookies: 1A405010000076E000000126 - Failed for total yeast and mold.

HG Lansing, 1116 E. Oakland Ave., in Lansing had product recalled that was sold between Dec. 27, 2018, and Dec. 30, 2018.

The products, batch number and reason for recall are listed:

  • Citrix: 1A4050100000F3D000000009 -Failed for E. coli and Salmonella.
  • Gelato: 1A4050100000F3D000000010 - Failed for chemical residue.
  • Green Crack: 1A4050100000F3D000000008 - Failed for chemical residue and bile-tolerant gram-negative bacteria, E. coli, Salmonella and total coliforms.
  • Oreoz: 1A4050100000F3D000000023 - Failed for chemical residue and E. coli and Salmonella

The Bureau of Marijuana Regulation (BMR) Director Andrew Brisbo said in a statement:

Medical marijuana patients should purchase products from licensed facilities and validate that the products being purchased have been tested under the law and rules of the state. Using marijuana products that contain levels of mold and/or chemical residue that the rules define as being potentially unsafe could lead to negative health consequences, particularly for immunocompromised patients.
BMR discovered these issues through routine monitoring of inventory and transactions in the statewide monitoring system. Continued safe patient access is at the heart of BMR’s mission and we continue to work with regulated facilities to ensure compliant practices with the laws and rules for the medical marijuana industry.